The fact that painkillers and Prozac have never been tested on the female physiology is but one example of the massive gender gap found in medical research.
Forbes Under 30 alum Sajith Wickramasekara scores an $850 million valuation for his biotech R&D startup Benchling. Amid the coronavirus pandemic, the company is helping big biotech companies work on potential therapeutics and vaccines for Covid-19.
For the sixth year in a row, Forbes, in partnership with TrueBridge Capital Partners, has searched the country for the next unicorns. In a tough year, these 25 fast-growing companies stand out.
The Joint Commission, accreditor of thousands of U. S. healthcare facilities is set to resume its surveys in June as hospitals and health systems re-open to visitors and begin to return hospital operations to a new normal.
Almost half of U.S. adults say they or someone in their home have “postponed or skipped medical care due to the coronavirus outbreak,” The Kaiser Family Foundation said in a new poll.
The French government has banned the prescription of hydroxychloroquine to treat symptoms of Covid-19 because of concerns over serious health risks from taking the drug. Is it the end of the road for the wonder cure?